Centrum Medyczne Sonomedico Spółka z Ograniczoną Odpowiedzialnością (KRS 0000645052, NIP 6342876891) is a Polish company, headquartered in Żory, Śląskie voivodeship. Centrum Medyczne Sonomedico operates in: Activities of head offices; management consultancy activities (PKD 70.10.A). Industry: Consulting and management. The company has been listed in the National Court Register since November 3, 2016. Centrum Medyczne Sonomedico's operations are currently suspended.
The company is currently suspended
Suspended since March 5, 2026
Negative equity
Negative equity in 2 of 4 available reporting years.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Centrum Medyczne Sonomedico
Identity
- Name
- Centrum Medyczne Sonomedico Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- November 3, 2016
- Registry status as of
- July 28, 2026
- Latest entry
- July 28, 2026
- Founding act
- 31.10.2016
Articles of association history (2)
- October 31, 2016: 31.10.2016
- March 22, 2018: 22.03.2018R.REP.A NUMER 1924/2018 NOTARIUSZ PRZEMYSŁAW CZUK,KANCELARIA NOTARIALNA W SIEMIANOWICACH ŚLĄSKICH ,UL.ŚLĄSKA 2 ZMIENIONO § 3
Activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. CENTRALNA, 23B, 1, 44-240, ŻORY, POLSKA
- Voivodeship
- ŚLĄSKIE
- District
- ŻORY
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-42397-53077-SEGIA-19
Risk and payment profile - Centrum Medyczne Sonomedico
Credibility rating
5 / 100
Very poor credibility
Insolvency risk
suspended
Significant formal threat
Closure risk
80
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/10 yrs
Board changes
0
0/10 yrs
PKD changes
1
1/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2022
Current: S (5/100)
Trend: stable (0.0 pts/year)
Spółka jest obecnie zawieszona – działalność operacyjna wstrzymana, wskaźnik wiarygodności odzwierciedla stan przed zawieszeniem.
Trade credit limit history
Standard limit from 2018–2022
Current: 0 PLN
Safe: 0 PLN
Operational status - Centrum Medyczne Sonomedico
Founded
November 3, 2016
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŻORY
ŚLĄSKIE
Primary PKD
70.10.A
Activities of head offices; management consultancy activities
Share capital
10.0 K PLN
99 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
4 years
2018–2022 · profitable: 1/4
Registry entries
33
latest: July 28, 2026
Risk signals
Revenue
N/A
2022
Net profit
-5.8 K PLN
2022
Assets
407.56 PLN
2022
Equity
-8.2 K PLN
2022
EBITDA
N/A
2022
no depreciation data
Valuation
0 PLN
suspended
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Centrum Medyczne Sonomedico.
No ratings
Related articles
News
Agora in 2026: return to dividends after 6 years (PLN 0.25), EBITDA of PLN 148m, PLN 200m strategic target
Agora S.A. - the Warsaw-based media holding (Gazeta Wyborcza, the Helios cinema chain, Radio TOK FM and Złote Przeboje, AMS outdoor, Yieldbird) - paid its first dividend in six years (PLN 0.25 per share, PLN 11.65m in total). The 2026–2029 strategy targets a cumulative PLN 2.50 per share in dividends and lifts EBITDA from PLN 148m to PLN 200m.
News
Archicom: a PLN 1.80 per share dividend recommendation after a record 2025 - 2,847 apartments sold, three times the market growth
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.
